- Report
- June 2025
- 194 Pages
Global
From €4332EUR$4,950USD£3,766GBP
- Report
- April 2025
- 225 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- June 2025
- 200 Pages
United States
From €2179EUR$2,490USD£1,894GBP
- Report
- June 2025
- 200 Pages
Europe
From €2179EUR$2,490USD£1,894GBP
- Report
- September 2025
- 85 Pages
United States
From €3063EUR$3,500USD£2,663GBP
- Report
- July 2025
- 193 Pages
Europe
From €3019EUR$3,450USD£2,625GBP
- Report
- November 2025
- 70 Pages
Africa, Middle East
From €3019EUR$3,450USD£2,625GBP
- Report
- November 2025
- 97 Pages
Asia Pacific
From €3457EUR$3,950USD£3,005GBP
- Report
- November 2025
- 100 Pages
Europe
From €3457EUR$3,950USD£3,005GBP
- Report
- November 2025
- 101 Pages
North America
From €3019EUR$3,450USD£2,625GBP
- Report
- October 2025
- 91 Pages
Middle East
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 135 Pages
United States
From €2232EUR$2,550USD£1,940GBP
- Report
- October 2025
- 110 Pages
North America
From €2844EUR$3,250USD£2,473GBP
- Report
- October 2025
- 82 Pages
Middle East
From €4245EUR$4,850USD£3,690GBP
- Report
- June 2025
- 96 Pages
Asia Pacific
From €3457EUR$3,950USD£3,005GBP
- Report
- June 2025
- 98 Pages
Europe
From €3457EUR$3,950USD£3,005GBP
- Report
- June 2025
- 88 Pages
North America
From €3019EUR$3,450USD£2,625GBP
- Report
- June 2025
- 80 Pages
Middle East, Africa
From €3019EUR$3,450USD£2,625GBP
- Report
- June 2025
- 65 Pages
United States
From €2232EUR$2,550USD£1,940GBP
- Report
- January 2022
- 249 Pages
Global
From €3282EUR$3,750USD£2,853GBP

Pharmacogenomics is a field of genomics that studies the relationship between an individual's genetic makeup and their response to drugs. It is used to develop personalized medicine, which is tailored to an individual's genetic profile. This field of genomics has the potential to revolutionize the way drugs are developed and prescribed, as it can help to identify which drugs are most effective for a particular patient. It can also help to reduce the risk of adverse drug reactions, as well as reduce the cost of drug development.
Pharmacogenomics is a rapidly growing field, with many companies investing in research and development. Examples of companies in the market include 23andMe, Genomics England, and Illumina. Show Less Read more